Zheng Xing Xing Ye Ri Bao·2025-08-29 08:41Market Overview - The pharmaceutical commercial sector experienced a decline of 0.12% on August 29, with RunDa Medical leading the drop [1] - The Shanghai Composite Index closed at 3857.93, up 0.37%, while the Shenzhen Component Index closed at 12696.15, up 0.99% [1] Stock Performance - Baiyang Pharmaceutical (301015) saw a significant increase of 6.58%, closing at 26.40 with a trading volume of 183,800 shares and a transaction value of 479 million [1] - Other notable gainers included Jianzhijia (605266) with a 3.05% increase, and Yingte Group (000411) with a 2.65% increase [1] - Conversely, RunDa Medical (603108) declined by 2.17%, closing at 17.57 with a trading volume of 237,400 shares [2] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 300 million in main funds, while retail investors saw a net inflow of 214 million [2] - The sector's capital flow indicates that while institutional investors withdrew funds, retail investors were actively buying [2] Individual Stock Capital Flow - SaiLi Medical (603716) had a main fund net inflow of 97.15 million, but saw a net outflow from retail investors of 56.18 million [3] - YiXinTang (002727) experienced a net inflow of 5.04 million from main funds, while retail investors had a slight outflow of 0.67 million [3] - Nanjing Medical (600713) had a net inflow of 2.51 million from main funds, with retail investors experiencing a net outflow of 5.07 million [3]